Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancers|July 29, 2023
The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and LumicanAikaterini Berdiaki, Eirini-Maria Giatagana, George Tzanakakis, et al.
Biomolecules|September 28, 2021
Lumican in Carcinogenesis-RevisitedEirini-Maria Giatagana, Aikaterini Berdiaki, Aristidis Tsatsakis, et al.
Cancers|August 28, 2020
Proteoglycans in the Pathogenesis of Hormone-Dependent Cancers: Mediators and EffectorsGeorge Tzanakakis, Eirini-Maria Giatagana, Andrey Kuskov, et al.
American Journal of Physiology. Cell Physiology|October 24, 2022
Rapamycin-induced autophagy in osteosarcoma cells is mediated via the biglycan/Wnt/β-catenin signaling axisEirini-Maria Giatagana, Aikaterini Berdiaki, Margrethe Gaardløs, et al.
Communications Biology|March 18, 2026
β-tubulin phosphorylation by Chk1 is required for normal spindle formation during cell divisionNikos Boutakoglou, Eleni Petsalaki, Sofia Balafouti, et al.
Biomolecules|April 3, 2021
Glycosaminoglycans: Carriers and Targets for Tailored Anti-Cancer TherapyAikaterini Berdiaki, Monica Neagu, Eirini-Maria Giatagana, et al.
Cancers|June 2, 2021
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma PathogenesisGeorge N Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, et al.
International Journal of Oncology|July 25, 2020
Lumican mediates HTB94 chondrosarcoma cell growth via an IGF‑IR/Erk1/2 axisAntonis Papoutsidakis, Eirini Maria Giatagana, Aikaterini Berdiaki, et al.
Molecular Biology Reports|September 14, 2023
RHAMM/hyaluronan inhibit β-catenin degradation, enhance downstream signaling, and facilitate fibrosarcoma cell growthAikaterini Berdiaki, Lydia-Nefeli Thrapsanioti, Eirini-Maria Giatagana, et al.
Pageof 2